Bicocca Open Archive

Logo unimib boa
ALBERTI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.219
AS - Asia 19.159
EU - Europa 10.744
SA - Sud America 2.040
AF - Africa 365
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 16
Totale 54.602
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.678
VN - Vietnam 6.063
SG - Singapore 5.462
CN - Cina 3.162
IT - Italia 2.491
HK - Hong Kong 1.990
RU - Federazione Russa 1.639
DE - Germania 1.571
BR - Brasile 1.525
SE - Svezia 1.108
IE - Irlanda 890
GB - Regno Unito 683
IN - India 512
FR - Francia 482
KR - Corea 400
UA - Ucraina 396
CA - Canada 343
FI - Finlandia 313
BD - Bangladesh 229
TR - Turchia 222
AR - Argentina 198
JP - Giappone 191
ID - Indonesia 183
AT - Austria 161
ES - Italia 160
NL - Olanda 150
IQ - Iraq 141
LT - Lituania 136
DK - Danimarca 126
MX - Messico 115
ZA - Sudafrica 114
PK - Pakistan 98
CH - Svizzera 89
PL - Polonia 85
SA - Arabia Saudita 82
EC - Ecuador 76
PH - Filippine 66
CO - Colombia 65
BE - Belgio 61
VE - Venezuela 60
AU - Australia 54
MA - Marocco 48
UZ - Uzbekistan 44
EG - Egitto 38
MY - Malesia 34
TW - Taiwan 34
PY - Paraguay 33
ET - Etiopia 31
GR - Grecia 31
CL - Cile 29
TN - Tunisia 28
IL - Israele 26
AE - Emirati Arabi Uniti 24
JO - Giordania 24
RO - Romania 24
PE - Perù 23
KZ - Kazakistan 22
PT - Portogallo 22
TH - Thailandia 22
DZ - Algeria 21
KE - Kenya 20
AZ - Azerbaigian 18
IR - Iran 17
CZ - Repubblica Ceca 16
AL - Albania 15
BO - Bolivia 15
UY - Uruguay 15
BG - Bulgaria 14
JM - Giamaica 14
NP - Nepal 14
OM - Oman 14
CR - Costa Rica 13
EU - Europa 13
HR - Croazia 13
AO - Angola 11
BH - Bahrain 11
HU - Ungheria 11
PA - Panama 11
HN - Honduras 10
LV - Lettonia 10
LY - Libia 10
NG - Nigeria 10
GT - Guatemala 9
PS - Palestinian Territory 9
LB - Libano 8
NO - Norvegia 8
SI - Slovenia 8
KG - Kirghizistan 7
MD - Moldavia 7
NI - Nicaragua 7
SC - Seychelles 7
TT - Trinidad e Tobago 7
BN - Brunei Darussalam 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
RS - Serbia 5
GE - Georgia 4
KW - Kuwait 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
Totale 54.536
Salva come PNG Salva come JPEG
Città #
Singapore 3.175
Ann Arbor 3.159
Dallas 2.697
Hong Kong 1.933
Ho Chi Minh City 1.830
Ashburn 1.749
Hanoi 1.522
San Jose 1.378
Milan 897
Dublin 863
Fairfield 860
Woodbridge 831
Wilmington 793
Frankfurt am Main 775
Chandler 718
Houston 580
New York 543
Dearborn 505
Santa Clara 497
Los Angeles 489
Chicago 403
Beijing 393
Hefei 393
Seattle 382
Jacksonville 370
Seoul 332
Princeton 330
The Dalles 297
Cambridge 293
Nanjing 213
Lauterbourg 209
Da Nang 202
Haiphong 194
Munich 193
Helsinki 171
Buffalo 165
Shanghai 161
São Paulo 161
Boardman 153
Moscow 151
Guangzhou 150
Council Bluffs 145
Ha Long 136
Vienna 123
Jakarta 119
Vilnius 115
Hải Dương 112
Orem 109
Biên Hòa 108
Quận Bình Thạnh 108
Tokyo 100
Lawrence 94
London 89
Ninh Bình 85
Rome 85
Chennai 84
Can Tho 83
Thái Nguyên 81
Altamura 77
Toronto 77
Vũng Tàu 76
Bắc Ninh 74
Dong Ket 69
Montreal 67
Denver 66
Baghdad 63
Basingstoke 63
Warsaw 63
Zurich 63
Nuremberg 61
Quận Một 60
Shenyang 58
Stockholm 58
Atlanta 57
Phoenix 57
Rio de Janeiro 57
Amsterdam 56
Lachine 55
Manchester 55
Nanchang 55
San Diego 54
Andover 52
Poplar 52
Turin 52
Bắc Giang 51
Hangzhou 51
Tianjin 51
Brooklyn 49
Changsha 49
Carate Brianza 45
Kent 45
Pune 44
Johannesburg 43
Phủ Lý 42
Brussels 41
Hebei 40
Mexico City 40
Jinan 39
Paris 39
Vinh 39
Totale 35.191
Salva come PNG Salva come JPEG
Nome #
Oxaliplatin-induced Alteration of Sodium-Calcium Exchanger as a Pivotal Element Leading to Peripheral Neurotoxicity and Necroptosis 766
SODIUM-CALCIUM EXCHANGER PIVOTAL ROLE IN OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY, AXONAL DAMAGE AND NECROPTOSIS 632
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models 605
Sodium-Calcium Exchanger 2 Role In An In Vitro Oxaliplatin-Induced Peripheral Neurotoxicity Model 586
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 575
In vitro neurotoxicity testing: lessons from chemotherapy-induced peripheral neurotoxicity 509
Translational Approach to Oxaliplatin Induced Peripheral Neurotoxicity - Neurophysiology: the Link between Bed and Bench "side" 503
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 500
A PILOT STUDY ON HEALTH-ECONOMICS BURDEN DUE TO CHEMOTHERAPY-INDUCED NEUROTOXICITY 482
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 462
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 445
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 441
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 440
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 440
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 417
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 417
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 411
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 404
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 397
Neuropatie periferiche da chemioterapia 391
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 390
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 380
Guillain-Barré syndrome related to COVID-19 infection 379
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 376
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 370
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 369
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 368
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 365
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 354
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 353
3D Digital tools in human anatomy teaching from peer-to-peer tutoring to clinically oriented approaches: a single center experience. 352
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 339
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 337
Oxaliplatin-induced Peripheral Neurotoxicity: role of ion channels/transporters in axonal damage. 330
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 328
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 321
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper 316
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 315
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 310
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 308
3D Digital tools in neuro-anatomy teaching: from peer-to-peer tutoring to clinically oriented approaches 307
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 306
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 305
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 301
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 300
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 300
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 299
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 297
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 296
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 295
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 294
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 292
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 290
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 289
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 287
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 285
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 285
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 285
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study 282
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 282
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 281
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 281
Severe, reversible nelarabine-induced neuropathy and myelopathy 275
Guillain–Barré Syndrome Associated with COVID-19 275
In vivo study of Carfilzomib-Induced Neuropathy 275
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 273
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 273
Histone deacetylases inhibitors: a new frontier for neuroprotection? 271
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 270
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 269
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools 269
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 268
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 267
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 264
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 263
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose 261
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 259
Neurophysiological examination of dorsal sural nerve 258
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 255
Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data 255
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 254
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 253
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 247
Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study. 247
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 245
Chemotherapy-induced neuropathy 244
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 244
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 242
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study 240
Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study. 240
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 238
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients 237
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 237
The significance of dorsal sural nerve recordings in early detecting oxaliplatin-induced peripheral neuropathy. 236
When progressive dysphagia could be related to an “old friend” – a case report 233
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 232
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial 231
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study 227
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 227
EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY 225
Totale 32.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.841
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021476 0 0 0 0 0 0 0 0 0 0 172 304
2021/20222.010 147 252 179 179 171 165 79 91 112 130 174 331
2022/20233.550 434 806 333 313 272 575 78 193 251 69 121 105
2023/20243.401 112 168 174 158 389 706 623 161 240 94 95 481
2024/20259.336 449 1.032 827 426 789 378 681 327 944 1.207 848 1.428
2025/202626.186 5.256 3.124 3.576 2.170 2.273 1.281 3.313 1.137 1.783 1.962 311 0
Totale 56.465